MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 185 filers reported holding MIRATI THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,048,067 | -28.8% | 28,189 | -13.2% | 0.00% | -33.3% |
| Q4 2022 | $1,472,122 | -69.8% | 32,490 | -55.3% | 0.01% | -77.8% |
| Q2 2022 | $4,882,000 | +272.7% | 72,722 | +356.2% | 0.03% | +440.0% |
| Q1 2022 | $1,310,000 | +310.7% | 15,940 | +785.1% | 0.01% | +400.0% |
| Q3 2021 | $319,000 | -80.9% | 1,801 | -82.6% | 0.00% | -83.3% |
| Q2 2021 | $1,669,000 | +50.2% | 10,330 | +104.2% | 0.01% | -25.0% |
| Q4 2020 | $1,111,000 | -20.8% | 5,058 | -53.5% | 0.01% | 0.0% |
| Q4 2019 | $1,402,000 | +34.8% | 10,879 | +7.7% | 0.01% | -20.0% |
| Q2 2019 | $1,040,000 | -82.9% | 10,100 | -87.8% | 0.01% | -84.4% |
| Q1 2019 | $6,078,000 | +443.2% | 82,924 | +214.4% | 0.06% | +392.3% |
| Q4 2018 | $1,119,000 | +156.7% | 26,379 | +85.8% | 0.01% | +85.7% |
| Q1 2018 | $436,000 | +78.0% | 14,200 | -32.3% | 0.01% | +40.0% |
| Q3 2017 | $245,000 | – | 20,975 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
| Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
| Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
| Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
| Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
| Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
| Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
| Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
| Trexquant Investment LP | 42,879 | $223,000 | 0.03% |